Frankfurt Stock Exchange · Technology
Invest in H100 Group AB stock from India
Indian and foreign residents can buy H100 Group AB (GS9) shares directly through Paasa.
By Paasa · Updated
H100 Group AB at a glance
- Price
- €0.17+€0.01 (3.79%)
- Market cap
- €57.39M
- Day range
- €0.16 – €0.17
- P/E
- —
- Dividend yield
- None
- Volume
- 1.00K
- 1 month
- +26.00%
- 6 months
- +6.00%
- YTD
- +6.00%
- 1 year
- -59.03%
- 5 years
- -83.04%
H100 Group AB statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | SEK 11.8M | SEK 3.0M | SEK 11.5K | SEK 2.4M | SEK 15.0M |
| Gross profit | SEK 79.1K | −SEK 743.3K | −SEK 7.9M | −SEK 513.4K | SEK 6.0M |
| Operating income | −SEK 340.5M | −SEK 5.2M | −SEK 7.8M | −SEK 3.6M | SEK 3.0M |
| Net income | −SEK 354.9M | −SEK 16.7M | −SEK 9.8M | −SEK 5.9M | SEK 2.7M |
| Earnings per share | −SEK 1.73 | −SEK 0.89 | −SEK 0.52 | −SEK 0.31 | SEK 0.14 |
| EBITDA | −SEK 30.5M | −SEK 4.0M | −SEK 7.7M | −SEK 5.7M | SEK 2.8M |
| Total assets | SEK 892.4M | SEK 114.0M | SEK 27.0M | SEK 36.7M | SEK 29.9M |
| Total debt | SEK 75.5M | SEK 0.0 | SEK 0.0 | SEK 0.0 | SEK 0.0 |
| Cash and short-term investments | SEK 30.6M | SEK 15.5M | SEK 843.5K | SEK 2.6M | SEK 5.6M |
| Shareholders' equity | SEK 814.2M | SEK 106.9M | SEK 25.7M | SEK 35.5M | SEK 28.9M |
| Operating cash flow | SEK 23.0M | −SEK 2.7M | −SEK 2.6M | −SEK 10.2M | SEK 3.2M |
| Free cash flow | −SEK 1.2B | −SEK 2.7M | −SEK 2.6M | −SEK 16.5M | −SEK 9.5M |
| Capital expenditure | −SEK 1.2B | SEK 0.0 | −SEK 374.8K | −SEK 6.3M | −SEK 12.7M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in SEK; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| LIMES Schlosskliniken | LIK.DE | €545.00 | €162.38M |
| Heidelberg Pharma | HPHA.DE | €2.58 | €120.70M |
| MPH Health Care | 93M1.DE | €26.00 | €111.32M |
| 4basebio | 88Q.DE | €6.35 | €98.33M |
| Apontis Pharma | APPH.DE | €11.00 | €91.63M |
| BRAIN Biotech | BNN.DE | €2.79 | €60.95M |
| DocCheck | AJ91.DE | €11.00 | €55.81M |
| FamiCord | V3V.DE | €2.95 | €51.42M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in H100 Group AB from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search GS9 and buy
Find H100 Group AB by name or by its ticker, GS9, and place your order.
Why invest in H100 Group AB from India
What H100 Group AB does
H100 Group AB is a health technology company which operates in the health and longevity sector. It provides AI-powered automation, digital growth tools, and integrated platform solutions for health and lifestyle service providers. H100 Group AB operates in the Software - Application industry within the Technology sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy H100 Group AB stock from India?
Yes. Indian residents and NRIs can buy H100 Group AB (GS9) shares directly through Paasa. H100 Group AB is listed on the Frankfurt Stock Exchange, in the Software - Application industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are H100 Group AB dividends taxed for Indian investors?
H100 Group AB trades on the Frankfurt Stock Exchange but is domiciled in Sweden, so any withholding on its dividends follows that country's rules rather than those of Germany. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell H100 Group AB shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.